Dupixent sales
RecordSTO-01M2KJ7XCG-3Y4BJ2059J-BJMGFC
Global · Q2 2026
Dupixent sales were 5.2 billion EUR in Q2 2026 (Sanofi).
Dupixent sales: every country and year, and how it is measured
- Publisher
- Sanofi
- Authority tier
- T3 Research
- Locator
- Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
Dupixent sales increased by 37.6% to €5.2 billion, above €5 billion per quarter for the first time
Checked: the figure 5.2 billion EURis stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
Sanofi. (2026). Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded. Retrieved September 15, 2026, from https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGFC
Other formats: MLA, Chicago, BibTeX
- MLA
- Sanofi. "Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded." 2026, https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGFC.
- Chicago
- Sanofi. "Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded." 2026. https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGFC.
- BibTeX
- @misc{sanofi2026dupixentbjmgfc, author = {{Sanofi}}, title = {Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGFC}, note = {Original source: https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- Sanofi · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
- Type
- Press release
- Published
- 30 July 2026
- Locator
- Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Permanent URL
- /stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGFC